FFRangio System vs uPMR 790
AI Verdict
Choose FFRangio System if…
Choose the FFRangio System if your primary need is to quickly and non-invasively assess coronary artery disease severity and optimize percutaneous coronary intervention (PCI) decisions. This system is ideal for cath labs seeking real-time, wire-free, and drug-free FFR guidance to confirm PCI effectiveness and differentiate functional patterns of CAD.
View FFRangio System →Choose uPMR 790 if…
Choose the uPMR 790 if your facility requires advanced, simultaneous PET/MR imaging for comprehensive diagnostics and research across multiple specialties like oncology, neurology, and cardiology. This system is best suited for scenarios demanding high-resolution, multi-modality data with AI-enhanced workflows for precise disease staging, treatment planning, and cutting-edge clinical research.
View uPMR 790 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FFRangio System | uPMR 790 |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Not publicly available (high-end medical equipment) |
| Deployment | SaaS, on-prem, hybrid | On-premise (installed in medical facilities) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FFRangio SystemTool A emphasizes an 'intuitive user interface' and 'seamless integration with cath lab boom and PACS', directly streamlining the clinician's experience during a procedure. While Tool B offers intelligent workflow features, these primarily focus on automating complex technical aspects of imaging acquisition rather than direct user interaction simplicity in a procedural context.
Clinical Value
FFRangio SystemTool A provides significant clinical value by offering wire-free and drug-free FFR guidance, directly reducing the invasiveness and potential risks of a critical diagnostic step in PCI. This innovation directly impacts patient safety and procedural efficiency. While Tool B offers superior diagnostic imaging across multiple specialties, Tool A's direct impact on a high-stakes interventional procedure provides a more immediate and tangible patient benefit.
Pricing & Value
FFRangio SystemBoth tools lack transparent public pricing, making a direct cost comparison impossible. However, Tool A explicitly highlights its ability to eliminate the need for invasive pressure wires and drugs, suggesting a more direct and quantifiable cost-saving aspect through reduced consumable expenses and potentially shorter procedure times, which adds clear value.
Enterprise Readiness
FFRangio SystemTool A explicitly states ISO 27001 certification for information security, which is a globally recognized standard demonstrating a robust approach to data protection and management. While Tool B states it 'would aim for HIPAA compliance,' Tool A's specific certification provides a stronger and more verifiable indicator of enterprise-level security and compliance readiness.
Innovation
uPMR 790Tool B showcases a broader and deeper technological innovation by integrating simultaneous PET/MRI with cutting-edge hardware like digital silicon photomultipliers and advanced AI-driven compressed sensing techniques to achieve industry-leading resolution. While Tool A's non-invasive FFR is a significant advancement in interventional cardiology, Tool B's advancements span a wider array of core imaging technologies and modalities.
Support & Docs
uPMR 790Tool B, United Imaging Healthcare, provides extensive details on its support infrastructure, including specific response times (less than 4 hours), various training programs (on-site, headquarters, joint), remote monitoring, and comprehensive service agreements. In contrast, Tool A, CathWorks, primarily offers access to Instructions For Use upon request and general contact information, without the same level of detailed public commitment to support services.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FFRangio System | uPMR 790 |
|---|---|---|
| Product Name | FFRangio System | uPMR 790 |
| Company | CathWorks | Shanghai United Imaging Healthcare Co. |
| Primary Application | Wire-free and drug-free 3D FFR guidance for optimizing PCI decisions in coronary artery disease. | Simultaneous, high-resolution PET/MR imaging with AI-enhanced workflows for clinical and research applications in oncology, neurology, and cardiology. |
| Key AI-driven Capabilities | Artificial intelligence aids in quick angiogram analysis; Real-time FFRangio values; Simulated pullback curve; Lesion Impact feature; Integrated sizing tool. | AI-enhanced workflows; Intelligent workflow features (automatic positioning, bed planning, attenuation correction); AI-assisted Compressed Sensing (uAIFI ACS). |
| Core Technology/Methodology | Wire-free and drug-free 3D FFR guidance using angiography and AI. | Simultaneous PET/MRI imaging with HD TOF PET platform and advanced MR acquisition techniques. |
Videos
Demos, reviews, and walkthroughs featuring FFRangio System and uPMR 790.